Loading clinical trials...

RECRUITING

Serum Endotoxin Assay to Predict the Development of Postoperative Infectious Complications and Systemic Inflammatory Response Following Percutaneous Nephrolithotomy.

NCT04669886•University of Miami

Summary

The aim of the study is to establish an infectious risk stratification system based on pre-and post-operative blood endotoxin profile.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Adults that is able to consent (≥ 18 years of age)
•Scheduled to undergo PCNL at Uhealth tower and Jackson Memorial Hospitals
•not currently immunosuppressed \[White blood count (WBC) \>= 2, not on immunosuppressive medications\]

Exclusion Criteria

•unable to consent and \< 18 years of age
•currently immunosuppressed (WBC \< 2, not on immunosuppressive medications)

Locations (1)

University of Miami

Miami, Florida, United States

Key Dates

Start Date

November 1, 2023

Primary Completion Date

September 30, 2026

Completion Date

December 1, 2026

Last Updated

September 3, 2025

Enrollment

150

ESTIMATED participants

Conditions

NephrolithiasisUrosepsis

Contacts

Hemendra N Shah

CONTACT

3052433246 hns35@miami.edu

Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes

NCT06576661

Kidney StoneNephrolithiasis

View study

RECRUITINGNA

Bendable Suction Ureteral Access Sheath Versus Conventional Ureteral Access Sheath in Management of Renal Stones Using Flexible Ureteroscopy

NCT06862141

NephrolithiasisFlexible Ureteroscopy

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 3, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Serum Endotoxin Assay to Predict the Development of Postoperative Infectious Complications and Systemic Inflammatory Response Following Percutaneous Nephrolithotomy.

Inclusion Criteria

Exclusion Criteria

Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes

Bendable Suction Ureteral Access Sheath Versus Conventional Ureteral Access Sheath in Management of Renal Stones Using Flexible Ureteroscopy

National Registry of Rare Kidney Diseases

Dual-process Mechanisms of Action for sipIT Intervention Effects in Patients With Urolithiasis

HoYAG vs TFL in miniPCNL With ClearPetra

Antibiotic Prophylaxis Before Shock Wave Lithotripsy